Indoco Remedies Ltd.

387.55 -8.50 ▼-2.2%

08 December 2023, 04:01:00 PM
Volume: 5,551

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.indoco.com
Market Cap 3,550.55 Cr.
Enterprise Value(EV) 3,962.39 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 12.31 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 31.30 Trailing Twelve Months Ending 2023-09
Industry PE 38.52 Trailing Twelve Months Ending 2023-09
Book Value / Share 115.93 Trailing Twelve Months Ending 2023-09
Price to Book Value 3.32 Calculated using Price: 385.30
Dividend Yield 0.58 Period Ending 2023-03
No. of Shares Subscribed 9.22 Cr. 92,150,355 Shares
FaceValue 2
About Indoco Remedies Ltd.
Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company caters to both domestic and International markets. Indoco has strengthened its wings in the international markets and offers complete solutions, including product development, manufacture and supply of Finished Dosages, APIs and Intermediates to generic companies worldwide. The company has a large basket of products backed by ANDAs / eCTD Dossiers and Drug Master Files (DMFs). Expertise in Research & Development, backward integration in API in select products, own CRO set-up, excellence in Finished Dosages manufacturing and a strong customer base will ensure consistent growth in the Company’s Domestic, as well as International business.

Indoco Remedies Ltd. Delivery

Delivered Qty
Traded Qty

Indoco Remedies Ltd. Performance

1 Day
-2.15%
1 Week
+6.93%
1 Month
+19.47%
3 Month
+16.68%
6 Month
+17.56%
1 Year
-2.37%
2 Year
-8.61%
5 Year
+75.52%
10 Year
+264.07%

Indoco Remedies Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 16.97 14.96 12.55 6.21 -0.43 3.60 12.85 18.50 14.72
Return on Capital Employed (%) 20.63 16.72 11.80 7.62 1.23 5.78 15.67 23.03 17.48
Return on Assets (%) 10.52 9.15 7.22 3.42 -0.24 1.96 7.23 10.63 8.64

Indoco Remedies Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 519 577 651 675 661 680 769 905 1,028 1,068
Non Curr. Liab. 65 66 147 125 116 101 158 157 261 299
Curr. Liab. 262 303 390 417 446 459 407 518 425 568
Minority Int. 2
Equity & Liab. 846 946 1,189 1,218 1,223 1,240 1,334 1,579 1,714 1,938
Non Curr. Assets 460 481 617 679 684 676 712 712 906 940
Curr. Assets 385 464 572 539 538 563 623 867 808 998
Misc. Exp. not W/O
Total Assets 846 946 1,189 1,218 1,223 1,240 1,334 1,579 1,714 1,938

Indoco Remedies Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 857 1,008 1,075 1,042 968 1,107 1,242 1,541 1,669 1,736
Other Income 2 4 6 8 7 5 9 3 2 6
Total Income 859 1,012 1,081 1,050 975 1,111 1,251 1,544 1,671 1,741
Total Expenditure -692 -840 -920 -910 -892 -986 -1,023 -1,215 -1,383 -1,476
PBIDT 167 172 160 140 83 126 227 330 288 265
Interest -11 -12 -6 -24 -21 -26 -22 -14 -25 -32
Depreciation -47 -61 -63 -68 -72 -71 -73 -79 -71 -76
Taxation -27 -17 -14 -7 6 -4 -39 -82 -51 -44
Exceptional Items
PAT 83 82 77 41 -3 24 93 155 142 113
Minority Interest 0
Share Associate 0
Other Related Items 0
Consolidated Net Profit 83 82 77 41 -3 24 93 155 142 113
Adjusted EPS 9 9 8 4 0 3 10 17 15 12

Indoco Remedies Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 99 109 112 89 123 132 123 82 174 179
Cash Fr. Inv. -41 -88 -111 -171 -135 -104 -56 -67 -121 -208
Cash Fr. Finan. -59 -20 -2 132 -39 -16 -64 -30 -44 23
Net Change -1 1 0 50 -51 12 3 -14 8 -7
Cash & Cash Eqvt 10 10 10 60 9 21 24 9 17 11

Indoco Remedies Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 58.69 58.69 58.69 58.69 58.69 58.69 58.69 58.73 58.74
Public 41.31 41.31 41.31 41.31 41.31 41.31 41.31 41.27 41.26
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Indoco Remedies Ltd. Announcements

Wed, 06 Dec 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
INDOCO REMEDIES RECEIVES TENTATIVE ANDA APPROVAL FROM USFDA FOR CANAGLIFLOZIN TABLETS
Wed, 01 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Wed, 01 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Indoco Remedies Ltd. Technical Scans

Fri, 08 Dec 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Week High Close Above Last Week High
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months

Indoco Remedies Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,235.50 -0.3%
Cipla Ltd. 98,444.27 1,218.85 -0.3%
Divi's Laboratories Ltd. 97,728.28 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. 79,790.42 5,542.00 +1.5%
Mankind Pharma Ltd. 78,250.95 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. 69,508.23 2,056.00 -2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 28.51 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.40 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.11 2,056.00 -2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 3.97 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.36 2,056.00 -2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,056.00 -2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,056.00 -2.2%

Indoco Remedies Ltd. FAQ's

What is Indoco Remedies share price?

Can I buy Indoco Remedies shares now?

What is the Dividend Yield of Indoco Remedies?

What is the Market Cap of Indoco Remedies?

What are the key metrics to analyse Indoco Remedies?

What is the 52 Week High and Low of Indoco Remedies?

What is the trend of Indoco Remedies share price?